| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.6623 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.6855 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7104 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7116 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7118 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7225 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7289 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7360 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7378 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7388 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7477 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7480 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7622 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7684 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7708 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7729 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7744 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7805 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7920 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7937 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.7969 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8007 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8033 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8034 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8061 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8087 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8120 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8131 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8139 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8151 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8161 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8164 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8181 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8210 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8245 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8317 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8369 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8421 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8436 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8503 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8504 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8525 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8583 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8622 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8651 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8718 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8719 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8725 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8758 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8763 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8853 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8871 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8882 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8914 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.8947 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9000 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9020 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9064 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9173 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9259 | scaled units | High-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9265 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9270 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9281 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9294 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9315 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9373 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9382 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9383 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9394 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9408 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9439 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9487 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9490 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9555 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9565 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9571 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9586 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9616 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9620 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9623 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9639 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9732 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9751 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9764 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9766 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9776 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9849 | scaled units | High-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9881 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9910 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9922 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9941 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9964 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 0.9971 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0000 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0013 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0025 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0029 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0037 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0067 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0119 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0122 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0133 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0138 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0141 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0145 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0145 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0150 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0161 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0167 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0186 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0213 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0233 | scaled units | Low-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0239 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0261 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0265 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0282 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0298 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0305 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0329 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0337 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0341 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0347 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0373 | scaled units | High-Dose | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0378 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0399 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0426 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0477 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0502 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0508 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0550 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0560 | scaled units | Low-Dose | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0615 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0621 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0650 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0697 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0704 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0745 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0754 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0824 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0838 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0895 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0899 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0985 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.0998 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1006 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1023 | scaled units | Low-Dose | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1060 | scaled units | High-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1067 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1083 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1090 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1158 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1203 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1242 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1253 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1457 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1496 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1512 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1538 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1556 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1606 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1640 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1653 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1693 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1702 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1748 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1753 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1801 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1851 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.1865 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2028 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2073 | scaled units | Placebo | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2113 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2187 | scaled units | Placebo | +47HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2262 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2330 | scaled units | Low-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2401 | scaled units | High-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2483 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2514 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2529 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2564 | scaled units | Placebo | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2620 | scaled units | Low-Dose | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2899 | scaled units | Placebo | +71HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2918 | scaled units | Placebo | +23HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.2957 | scaled units | Placebo | +4HR POST INFUSION |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.3463 | scaled units | High-Dose | -0.5HR |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.5461 | scaled units | Low-Dose | BASELINE |
| Reversed phase NEGATIVE ION MODE | pseudouridine | 1.6140 | scaled units | Low-Dose | -0.5HR |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|